{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The New Biology","title":"Creating “a post-pandemic world” — Jacob Glanville","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/897ac51b\"></iframe>","width":"100%","height":180,"duration":5291,"description":"Centivax is developing universal flu vaccines designed to protect against all strains of influenza—past, present, and future. In this interview, we speak with Jacob Glanville, the company’s co-founder and CEO.\nSubscribe to Asimov Press: https://press.asimov.com\nProduced and edited by Chris Gates, crgstudio.co\n00:49 Why flu vaccines need constant updating\n03:07 How influenza infects a cell\n06:39 Why our immune system doesn’t generate broadly-neutralizing antibodies\n16:07 Mutations and animals\n23:42 What is vaccine efficacy?\n28:55 Designing a universal flu vaccine\n37:40 The idea behind Centivax\n44:16 Clinical trials\n57:33 The business case for eradication\n1:03:26 How to eradicate the flu\n1:07:26 Could we make broad vaccines for the common cold?\n1:09:07 Building a universal snake antivenom\n1:23:09 Antivenom cocktails","thumbnail_url":"https://img.transistorcdn.com/Cdlp_4Y2x0oxnTGtoVdklrgCMQQ-ARclU1VI-dDVZCI/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jYTRi/NTg1Yzc3YmRiZjg1/ZjNmYmNkNjAyYjFl/NjllMS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}